Patents by Inventor Laurel MYDOCK-MCGRANE

Laurel MYDOCK-MCGRANE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220235087
    Abstract: The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    Type: Application
    Filed: April 6, 2022
    Publication date: July 28, 2022
    Inventors: James W. JANETKA, Laurel MYDOCK-MCGRANE
  • Publication number: 20200407390
    Abstract: The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    Type: Application
    Filed: July 10, 2020
    Publication date: December 31, 2020
    Inventors: James W. JANETKA, Laurel MYDOCK-MCGRANE
  • Patent number: 10738070
    Abstract: The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: August 11, 2020
    Assignee: Fimbrion Therapeutics, Inc.
    Inventors: James W. Janetka, Laurel Mydock-McGrane
  • Publication number: 20200002303
    Abstract: The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    Type: Application
    Filed: March 11, 2017
    Publication date: January 2, 2020
    Inventors: James W. JANETKA, Laurel MYDOCK-MCGRANE
  • Publication number: 20190106451
    Abstract: The present invention relates to mannoside derivative compounds useful as inhibitors of FimH and methods for the treatment or prevention of urinary tract infection.
    Type: Application
    Filed: March 23, 2017
    Publication date: April 11, 2019
    Inventors: James W. JANETKA, Laurel MYDOCK-MCGRANE